EP2423331

Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    31.3.2005
  • EP published:
    8.5.2019
  • EP application number:
    11178200.9
  • Max expiry date:
    30.3.2025
  • Title:
    Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

Timeline

Today
31.3.2005EP application
8.5.2019EP Publication

Owner

  • Name:
    The General Hospital Corporation
  • Address:
    55 Fruit Street, 02114, Boston, MA, US
  • Name:
    Dana-Farber Cancer Institute, Inc.
  • Address:
    450 Brookline Avenue, 02215, Boston, MA, US

Inventor

  • Name:
    Bell, Daphne Winifred
  • Address:
    Chevy Chase, MD, US
  • Name:
    Haber, Daniel A.
  • Address:
    Chestnut Hill, MA, US
  • Name:
    Janne, Pasi Antero
  • Address:
    Newton, MA, US
  • Name:
    Johnson, Bruce E.
  • Address:
    Brookline, MA, US
  • Name:
    Lynch, Thomas J.
  • Address:
    New Haven, CT, US
  • Name:
    Meyerson, Matthew
  • Address:
    Concord, MA, US
  • Name:
    Paez, Juan Guillermo
  • Address:
    Boston, MA, US
  • Name:
    Sellers, William R.
  • Address:
    Brookline, MA, US
  • Name:
    Settleman, Jeffrey E.
  • Address:
    Mill Valley, CA, US
  • Name:
    Sordella, Raffaella
  • Address:
    Syosset, NY, US

Priority

  • Number:
    558218 P
  • Date:
    31.3.2004
  • Country:
    US
  • Number:
    561095 P
  • Date:
    9.4.2004
  • Country:
    US
  • Number:
    565753 P
  • Date:
    27.4.2004
  • Country:
    US
  • Number:
    565985 P
  • Date:
    27.4.2004
  • Country:
    US
  • Number:
    574035 P
  • Date:
    25.5.2004
  • Country:
    US
  • Number:
    577916 P
  • Date:
    7.6.2004
  • Country:
    US
  • Number:
    592287 P
  • Date:
    29.7.2004
  • Country:
    US

Classification

  • Categories:
    C12Q 1/68, C07H 21/04

Upload documents